期刊文献+

应用变性高效液相色谱技术建立胸苷酸合成酶基因多态检测平台

Simultaneous detection of polymorphisms in the 3'- and 5'-UTR of thymidylate synthase gene using denaturing high-performance liquid chromatography
下载PDF
导出
摘要 TS基因5′非翻译区(5′untranslation region,5′UTR)增强子区域(TS enhancer region,TSER)存在28bp的2次(2R)、3次(3R)的串联重复多态,在3R等位基因第二次重复中还存在一个G→C的单核苷酸多态性(single nu-cleotide polymorphisms,SNPs),同时在3′非翻译区(3′untranslation region,3′UTR)存在6个碱基片段缺失/插入多态。这些多态形式的存在影响了TS基因mRNA的稳定和翻译效率,并可导致不同TS基因型肿瘤患者对以5-fuorouracil(5-FU)为基础的化疗疗效产生差异。为提高TS基因型临床检测的效率和准确性,方便、快捷、准确和自动化区分各种纯合及杂合基因型,设计多重PCR反应,同时扩增TS基因5′和3′非翻译区多态所处片段。利用DHPLC技术建立TS基因多态性检测平台,在非变性条件下,通过优化DHPLC洗脱梯度,同时检测5′TSER区的串联重复多态和3′UTR片段长度多态;在变性条件下,检测5′TSER区单核苷酸多态。同时采用PCR-RFLP和DNA测序方法,验证DHPLC分析结果。 Polymorphism which is either in the thymidylate synthase (TS)enhancer region (TSER) of the 5-primer untranslation region (5' UTR) or in the 3-primer untranslation region (3' UTR) has been reported to be associated with the alterations in TS mRNA and protein levels. The TSER is characteristic of the presence of variable double (2R) and triple (3R) number tandem repeats (VNTRs). In addition to VNTRs, single nucleotide polymorphism (SNPs) in 3R, as well as the polymorphism of the fragment length(FLP) in the TS 3'-UTR which is characteristic of the presence or absence of a 6 bpnucleotide fragment, has recently been reported to be associated with the response to 5-fuorouracil (5-FU)-based chemotherapy. The aim of the present study was to develop a specifc denaturing high-performance liquid chromatography (DHPLC) method for the rapid and simultaneous detection of these variations in clinical samples. Multi-PCR primers were designed to amplify the two regions simultaneously, The 8.6 min DHPLC gradient was optimized to include the analysis of multiplexed TSER/3' UTR chromatogram peaks, allowing for the simultaneous detection of 28 bp VNTRs and 6 bp FLP under nondenaturing conditions (50℃). The optimal melting temperature was determined experimentally for the detection of SNP in the TSER VNTRs. Finally, the DHPLC analysis was verified in parallel with PCR-RFLP and sequencing. The optimized DHPLC method resolved 100% of the known TS variations, discriminated between homozygous and heterozygous genotypes. This developed DHPLC method could permit the rapid, sensitive, and accurate identification of the TS genotypes (VNTRs, SNPs, and FLP).
出处 《遗传》 CAS CSCD 北大核心 2007年第3期306-312,共7页 Hereditas(Beijing)
基金 江苏省卫生厅科研项目基金(编号:H200142) 江苏省肿瘤防治研究所青年基金(编号:ZQ200412)资助~~
关键词 DHPLC 胸苷酸合成酶 基因多态性检测 DHPLC thymidylate synthase genetic polymorphism detection
  • 相关文献

参考文献18

  • 1Kawakami K,Watanabe G.Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.Cancer Res,2003,63(18):6004-6007.
  • 2Mandola MV,Stoehlmacher J,Muller-Weeks S,Cesarone G,Yu MC,Lenz HJ,Ladner RD.A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.Cancer Res,2003,63(11):2898-2904.
  • 3Mandola MV,Stoehlmacher J,Zhang W,Groshen S,Yu MC,Iqbal S,Lenz HJ,Ladner RD.A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels.Pharmacogenetic,2004,14(5):319-327.
  • 4Marsh S,Collie-Duguid ES,Li T,Liu X,McLeod HL l.Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.Genomics,1999,58(3):310-312.
  • 5Luo HR,Lu XM,Yao YG,Horie N,Takeishi K,Jorde LB,Zhang YP.Length polymorphism of thymidylate synthase regulatory region in Chinese populations and evolution of the novel alleles.Biochem Genet,2002,40(1-2):41-51.
  • 6Ishida Y,Kawakami K,Tanaka Y,Kanehira E,Omura K,Watanabe G.Association of thymidylate synthase gene polymorphism with its mRNA and protein expression and with prognosis in gastric cancer.Anticancer Res,2002,22(5):2805-2809.
  • 7Rose MG,Farrell MP,Schmitz JC.Thymidylate synthase:a critical target for cancer chemotherapy.Clin Colorectal Cancer,2002,1(4):220-229.
  • 8Zhang Z,Shi Q,Sturgis EM,Spitz MR,Hong WK,Wei Q.Thymidylate synthase 5'-and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.Clin Cancer Res,2004,10(23):7903-7910.
  • 9Ulrich CM,Bigler J,Bostick R,Fosdick L,Potter JD.Thymidylate synthase promoter polymorphism,interaction with folate intake,and risk of colorectal adenomas.Cancer Res,2002,62(12):3361-3364.
  • 10Graziano F,Kawakami K,Watanabe G,Ruzzo A,Humar B,Santini D,Catalano V,Ficarelli R,Merriman T,Panunzi S,Testa E,Cascinu S,Bearzi I,Tonini G,Magnani M.l.Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.Int J Cancer,2004,112(6):1010-1014.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部